CAS: 332012-40-5 - Telatinib
Formula:C20H16ClN5O3
InChI:InChI=1S/C20H16ClN5O3/c1-22-19(27)16-10-12(6-8-23-16)11-29-20-17-15(7-9-28-17)18(25-26-20)24-14-4-2-13(21)3-5-14/h2-10H,11H2,1H3,(H,22,27)(H,24,25)
InChI key:InChIKey=QFCXANHHBCGMAS-UHFFFAOYSA-N
SMILES:O=C(NC)C1=NC=CC(=C1)COC2=NN=C(NC3=CC=C(Cl)C=C3)C=4C=COC24
- Synonyms:
- 2-Pyridinecarboxamide,4-[[[4-[(4-chlorophenyl)amino]furo[2,3-d]pyridazin-7-yl]oxy]methyl]-N-methyl-
- 4-[[[4-[(4-Chlorophenyl)amino]furo[2,3-d]pyridazin-7-yl]oxy]methyl]-N-methyl-2-pyridinecarboxamide
- Bay 57-9352
- Bay57-9352
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Telatinib REF: IN-DA00C6JYCAS: 332012-40-5 | 98% | To inquire | Tue 10 Dec 24 | |
Telatinib REF: TM-T6166CAS: 332012-40-5 | 97.61% - 99.81% | 34.00 €~342.00 € | Mon 16 Dec 24 | |
Telatinib REF: TR-T015700CAS: 332012-40-5 | - - - | 260.00 €~1,770.00 € | Tue 21 Jan 25 | |
Telatinib REF: 3D-HNA01240CAS: 332012-40-5 | Min. 95% | To inquire | Tue 21 Jan 25 |
Ref: IN-DA00C6JY
1mg | 105.00 € | ||
5mg | 166.00 € | ||
10mg | 268.00 € | ||
25mg | 504.00 € | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Telatinib
CAS:332012-40-5
Telatinib (Bay 57-9352) inhibits VEGFR2/3, c-Kit, PDGFRα with IC50s: 6 nM, 4 nM, 1 nM, …
Formula:
C20H16ClN5O3
Purity:
97.61% - 99.81%
Color and Shape:
Solid
Molecular weight:
409.83
- Inhibitors
- Tyrosine Kinase/Adaptors
- VEGFR
- PDGFR
- See more categories
- c-Kit
Ref: TM-T6166
10mg | 39.00 € | ||
25mg | 78.00 € | ||
50mg | 113.00 € | ||
1mL*10mM (DMSO) | 34.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Telatinib
Controlled ProductCAS:332012-40-5
Applications Telatinib small-molecule inhibitor of vascular endothelial growth factor receptors 2 and 3 (VEGFR-2/-3) and …
Formula:
C20H16ClN5O3
Color and Shape:
Neat
Molecular weight:
409.826
Ref: TR-T015700
10mg | 260.00 € | ||
100mg | 1,770.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Telatinib
CAS:332012-40-5
Telatinib is a tyrosine kinase inhibitor that belongs to the group of cancer drugs. It …
Formula:
C20H16ClN5O3
Purity:
Min. 95%
Molecular weight:
409.83 g/mol
Ref: 3D-HNA01240
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025